Group One Trading’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-15,526
| Closed | -$121K | – | 2840 |
|
|
2025
Q1 | $121K | Buy |
+15,526
| New | +$121K | ﹤0.01% | 951 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 2733 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 2376 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 2428 |
|
|
2024
Q1 | – | Sell |
-2,375
| Closed | -$26.7K | – | 2476 |
|
|
2023
Q4 | $26.7K | Sell |
2,375
-43,614
| -95% | -$491K | ﹤0.01% | 1202 |
|
|
2023
Q3 | $315K | Buy |
45,989
+23,351
| +103% | +$160K | ﹤0.01% | 632 |
|
|
2023
Q2 | $206K | Buy |
22,638
+13,602
| +151% | +$124K | ﹤0.01% | 689 |
|
|
2023
Q1 | $58.4K | Buy |
9,036
+7,724
| +589% | +$49.9K | ﹤0.01% | 979 |
|
|
2022
Q4 | $8.32K | Sell |
1,312
-34,844
| -96% | -$221K | ﹤0.01% | 1471 |
|
|
2022
Q3 | $224K | Buy |
36,156
+2,683
| +8% | +$16.6K | ﹤0.01% | 789 |
|
|
2022
Q2 | $296K | Buy |
33,473
+9,519
| +40% | +$84.2K | ﹤0.01% | 757 |
|
|
2022
Q1 | $202K | Sell |
23,954
-6,873
| -22% | -$58K | ﹤0.01% | 1029 |
|
|
2021
Q4 | $314K | Buy |
30,827
+13,021
| +73% | +$133K | ﹤0.01% | 1055 |
|
|
2021
Q3 | $346K | Buy |
17,806
+13,130
| +281% | +$255K | ﹤0.01% | 949 |
|
|
2021
Q2 | $82K | Buy |
+4,676
| New | +$82K | ﹤0.01% | 1392 |
|